Cargando…

COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome

Zhou et al. (Nature) and Hoffmann et al. (Cell) identify ACE2 as a SARS-CoV-2 receptor, and the latter show its entry mechanism depends on cellular serine protease TMPRSS2. These results may explain proinflammatory cytokine release via the associated angiotestin II pathway and a possible therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hirano, Toshio, Murakami, Masaaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175868/ https://www.ncbi.nlm.nih.gov/pubmed/32325025 http://dx.doi.org/10.1016/j.immuni.2020.04.003

Ejemplares similares

How COVID-19 induces cytokine storm with high mortality
por: Hojyo, Shintaro, et al.
Publicado: (2020)

A Four-Step Model for the IL-6 Amplifier, a Regulator of Chronic Inflammations in Tissue-Specific MHC Class II-Associated Autoimmune Diseases
por: Murakami, Masaaki, et al.
Publicado: (2011)

Effectiveness of Tocilizumab in a COVID-19 Patient with Cytokine Release Syndrome
por: Uslu, Sadettin
Publicado: (2020)

The effect of tocilizumab on cytokine release syndrome in COVID-19 patients
por: de Cáceres, Carmen, et al.
Publicado: (2020)

Utilizing tocilizumab for the treatment of cytokine release syndrome in COVID-19
por: Hassoun, Ali, et al.
Publicado: (2020)

Editorial: Cytokine Release Syndrome in COVID-19: Mechanisms and Management
por: Hu, Tao
Publicado: (2022)

The molecular mechanisms of chronic inflammation development
por: Murakami, Masaaki, et al.
Publicado: (2012)

The Pathological and Physiological Roles of IL-6 Amplifier Activation
por: Murakami, Masaaki, et al.
Publicado: (2012)

Cytokine release syndrome
por: Shimabukuro-Vornhagen, Alexander, et al.
Publicado: (2018)

Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality
por: Moradian, Negar, et al.
Publicado: (2021)

Biomarkers of Cardiac Stress and Cytokine Release Syndrome in COVID-19: A Review
por: Gordon, Jonathan S., et al.
Publicado: (2021)

A Validated Mathematical Model of the Cytokine Release Syndrome in Severe COVID-19
por: Reis, Ruy Freitas, et al.
Publicado: (2021)

Cytokine release syndrome: grading, modeling, and new therapy
por: Liu, Delong, et al.
Publicado: (2018)

Tocilizumab in Severe COVID-19 Pneumonia and Concomitant Cytokine Release Syndrome
por: van Kraaij, Tom DA, et al.
Publicado: (2020)

Rituximab and Cytokine Release Syndrome
por: Kulkarni, Hrishikesh S., et al.
Publicado: (2012)

Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19
por: Luo, Wei, et al.
Publicado: (2020)

In vitro Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19
por: Santoso, Clarissa S., et al.
Publicado: (2020)

Therapeutic Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19
por: Santoso, Clarissa S., et al.
Publicado: (2021)

Biological therapy as an alternative treatment for cytokine release syndrome in patients with COVID-19()
por: Solis Cartas, Urbano
Publicado: (2022)

A new year, but familiar challenges from COVID-19 in the USA
por: Burki, Talha Khan
Publicado: (2021)

Etanercept as a new therapeutic option for cytokine release syndrome following chimeric antigen receptor T cell therapy
por: Zhang, Lina, et al.
Publicado: (2021)

Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
por: Zhang, Chi, et al.
Publicado: (2020)

The Middle East respiratory syndrome puzzle: A familiar virus, a familiar disease, but some assembly still required
por: Mackay, Ian M., et al.
Publicado: (2015)

Levels of the TNF-Related Cytokine LIGHT Increase in Hospitalized COVID-19 Patients with Cytokine Release Syndrome and ARDS
por: Perlin, David S., et al.
Publicado: (2020)

Tocilizumab in a child with acute lymphoblastic leukaemia and COVID-19-related cytokine release syndrome()
por: Velasco Puyó, Pablo, et al.
Publicado: (2020)

Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome: A Cautionary Case Report
por: Radbel, Jared, et al.
Publicado: (2020)

Cytokine Release Syndrome in COVID-19 Patients, A New Scenario for an Old Concern: The Fragile Balance between Infections and Autoimmunity
por: Picchianti Diamanti, Andrea, et al.
Publicado: (2020)

Therapeutic plasma exchange in life-threatening COVID-19 and associated cytokine release syndrome
por: Faqihi, Fahad, et al.
Publicado: (2020)

Tocilizumab Use in COVID-19 Cytokine-release Syndrome: Retrospective Study of Two Centers
por: Nasa, Prashant, et al.
Publicado: (2020)

Cytokine Release Syndrome (CRS) and Nicotine in COVID-19 Patients: Trying to Calm the Storm
por: Gonzalez-Rubio, Jesus, et al.
Publicado: (2020)

Role of IL-6 inhibitor in treatment of COVID-19-related cytokine release syndrome
por: Du, Peng, et al.
Publicado: (2021)

Interleukin-6 signaling blockade treatment for cytokine release syndrome in COVID-19 (Review)
por: Chen, Jia-Jie, et al.
Publicado: (2021)

Clinical characterization and risk factors associated with cytokine release syndrome induced by COVID-19 and chimeric antigen receptor T-cell therapy
por: Hong, Ruimin, et al.
Publicado: (2020)

Clinical Characterization and Risk Factors Associated with Cytokine Release Syndrome Induced By COVID-19 and Chimeric Antigen Receptor T-Cell Therapy
por: Hong, Ruimin, et al.
Publicado: (2020)

Targeting the A(3) adenosine receptor to treat cytokine release syndrome in cancer immunotherapy
por: Cohen, Shira, et al.
Publicado: (2019)

Cytokine Release Syndrome: Current Perspectives
por: Murthy, Hemant, et al.
Publicado: (2019)

Decreased serum phosphate levels are a useful biomarker to predict occurrence and severity of cytokine release syndrome in chimeric antigen receptor T‐cell therapy
por: Nakamura, Naokazu, et al.
Publicado: (2022)

Successful immunomodulation in kidney transplant recipients with cytokine release syndrome after coronavirus disease
por: Takamoto, Daiji, et al.
Publicado: (2022)

Corticosteroids for critically ill COVID-19 patients with cytokine release syndrome: a limited case series
por: Yang, Stephen Su, et al.
Publicado: (2020)

Tocilizumab and Cytokine Release Syndrome in COVID-19 Pneumonia: Experience From a Single Center in Pakistan
por: Hassan, Muhammad, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vnntt23pbrc2iq4qvh1fd5o2b7